BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35426079)

  • 1. The impact of body mass index on prognosis in patients with colon carcinoma.
    Fuchs J; Schellerer VS; Brunner M; Geppert CI; Grützmann R; Weber K; Merkel S
    Int J Colorectal Dis; 2022 May; 37(5):1107-1117. PubMed ID: 35426079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
    Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
    Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overweight/obese status associates with favorable outcome in patients with metastatic nasopharyngeal carcinoma: a 10-year retrospective study.
    Li W; Shen LJ; Chen T; Sun XQ; Zhang Y; Wu M; Shu WH; Chen C; Pan CC; Xia YF; Wu PH
    Chin J Cancer; 2016 Aug; 35(1):75. PubMed ID: 27507261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical consequences of chemotherapy dose reduction in obese patients with stage III colon cancer: A retrospective analysis from the PETACC 3 study.
    Stocker G; Hacker UT; Fiteni F; John Mahachie J; Roth AD; Van Cutsem E; Peeters M; Lordick F; Mauer M
    Eur J Cancer; 2018 Aug; 99():49-57. PubMed ID: 29906734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of body mass index on short-term and long-term surgical outcomes of laparoscopic hepatectomy in liver carcinoma patients: a retrospective study.
    Zhao L; Wang J; Kong J; Zheng X; Yu X
    World J Surg Oncol; 2022 May; 20(1):150. PubMed ID: 35538493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and Its Impact on Outcomes in Patients With Stage III Colon Cancer Receiving Adjuvant Chemotherapy.
    Ding PQ; Batra A; Xu Y; McKinnon GP; Cheung WY
    Clin Colorectal Cancer; 2020 Sep; 19(3):209-218. PubMed ID: 32291245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial.
    Di Cosimo S; Porcu L; Agbor-Tarh D; Cinieri S; Franzoi MA; De Santis MC; Saura C; Huober J; Fumagalli D; Izquierdo M; Piccart M; Daidone MG; de Azambuja E
    Breast Cancer Res; 2020 Oct; 22(1):115. PubMed ID: 33109233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis.
    Sun L; Zhu Y; Qian Q; Tang L
    Medicine (Baltimore); 2018 Jun; 97(26):e11220. PubMed ID: 29952978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
    Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A paradox between preoperative overweight/obesity and change in weight during postoperative chemotherapy and its relationship to survival in stage Ⅱ and Ⅲ colorectal cancer patients.
    Hu C; Zhang Q; Jin X; Zhang L; Zhang Y; Zhu Q; Tang M; Lyv G; Shi H
    Clin Nutr; 2021 Apr; 40(4):2410-2419. PubMed ID: 33183882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer.
    Tralongo AC; Caspani F; Proserpio I; Volpi L; Campiotti L
    Intern Emerg Med; 2023 Jan; 18(1):297-303. PubMed ID: 36357605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal BMI predicts the survival benefits of inductive docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced oral squamous cell carcinoma.
    Zhao TC; Liang SY; Ju WT; Liu Y; Tan YR; Zhu DW; Zhang CP; Zhang ZY; Zhong LP
    Clin Nutr; 2020 Sep; 39(9):2751-2758. PubMed ID: 31839432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body mass index at diagnosis and survival among colon cancer patients enrolled in clinical trials of adjuvant chemotherapy.
    Sinicrope FA; Foster NR; Yothers G; Benson A; Seitz JF; Labianca R; Goldberg RM; Degramont A; O'Connell MJ; Sargent DJ;
    Cancer; 2013 Apr; 119(8):1528-36. PubMed ID: 23310947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer.
    Alipour S; Kennecke HF; Woods R; Lim HJ; Speers C; Brown CJ; Gill S; Renouf DJ; Cheung WY
    J Gastrointest Cancer; 2013 Jun; 44(2):203-10. PubMed ID: 23264206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the body mass index and the clinical findings in patients with acute heart failure: evaluation of the obesity paradox in patients with severely decompensated acute heart failure.
    Matsushita M; Shirakabe A; Hata N; Shinada T; Kobayashi N; Tomita K; Tsurumi M; Okazaki H; Yamamoto Y; Asai K; Shimizu W
    Heart Vessels; 2017 May; 32(5):600-608. PubMed ID: 27778068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity paradox in group 1 pulmonary hypertension: analysis of the NIH-Pulmonary Hypertension registry.
    Mazimba S; Holland E; Nagarajan V; Mihalek AD; Kennedy JLW; Bilchick KC
    Int J Obes (Lond); 2017 Aug; 41(8):1164-1168. PubMed ID: 28209971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High Body Mass Index Worsens Survival in Patients with Esophageal Squamous Cell Carcinoma after Esophagectomy.
    Duan XF; Tang P; Shang XB; Jiang HJ; Zhao Q; Yu ZT
    Dig Surg; 2017; 34(4):319-327. PubMed ID: 28099956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity is an independent prognostic variable in colon cancer survivors.
    Sinicrope FA; Foster NR; Sargent DJ; O'Connell MJ; Rankin C
    Clin Cancer Res; 2010 Mar; 16(6):1884-93. PubMed ID: 20215553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials.
    Dahlberg SE; Schiller JH; Bonomi PB; Sandler AB; Brahmer JR; Ramalingam SS; Johnson DH
    J Thorac Oncol; 2013 Sep; 8(9):1121-7. PubMed ID: 23887169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.